Electromagnetic compatibility

Electromagnetic compatibility has two connected sides: controlling disturbances generated by equipment and maintaining acceptable behavior when equipment is exposed to disturbances. A passing emissions result does not establish immunity, and immunity to one disturbance does not establish immunity to all others. The IEC 61000 family includes documents with different roles. The practical task is to identify the relevant product, environment, disturbance and acceptance criteria before deciding which methods and evidence can support the intended use.

A basic test method describes how a particular phenomenon is applied or measured. A generic or product-family document can address the conditions and criteria relevant to a defined class of equipment. These roles should not be collapsed into a statement that a product simply passes IEC 61000. Selected IEC catalogue metadata identifies a radiated-immunity method; electrostatic discharge has a separate reference. The family designation alone does not specify a complete product assessment or regulatory route.

Selected method records are IEC 61000-4-2:2025 and IEC 61000-4-3:2020. They concern different disturbance phenomena and do not share a single family edition. A product or product-family standard can invoke a specific method edition and define relevant test levels and performance criteria. Updating a method publication does not automatically update the basis of an existing product evaluation. The selected official records were checked on 19 October 2026, with dates limited to the granularity supported by the source.

For a controller with several input ports and network connections, the test configuration includes cable arrangements, connected equipment and operating modes. A quiet standby configuration may not represent the state in which interference is most likely or its consequences most significant. The report links those choices to the intended use and monitored functions. Changing a cable, enclosure, power supply or software mode can affect the relevance of earlier evidence, even when the product retains the same commercial name.

FDA’s EMC guidance addresses testing and information for medical device submissions. It is a sector-specific context. FCC radio-frequency rules address another part of U.S. regulation, and neither route can be inferred from an international immunity test alone. The appropriate product requirements, recognized methods and submission conditions need explicit identification. A test method citation is therefore different from evidence that a regulator accepts the complete product and its use environment.

Examine the equipment version, ports, accessories, cable lengths, power arrangement and operating states. What functions were monitored during and after exposure, and how were performance criteria selected? Are deviations, interruptions and recoveries described rather than hidden behind a summary pass? Does the report identify the method edition and environmental basis? These questions distinguish a technically reproducible test from a conclusion about the product’s suitability for an application. An untested configuration requires a reasoned relationship to the evaluated sample.

EMC evidence depends strongly on configuration and the question being asked. A report can be valid for its test setup without representing every installation or operating mode. The public sources support the separation of family structure, methods and regulatory use; they do not provide universal test levels or acceptance criteria. This reference does not reproduce IEC procedures or choose a complete EMC program for an unspecified product. Such a program needs the actual equipment, environment and applicable technical and legal requirements.

For a medical application, medical electrical equipment explains the general and collateral reference set. ICT safety concerns a separate safety subject. Testing and calibration laboratories helps assess the report’s scope. The evidence tool is useful for comparing setups, operating modes and acceptance criteria before treating two EMC reports as interchangeable.

The sources were checked on 19 October 2026. IEC publication identities are cited as bibliographic metadata only. FDA’s guidance supports the medical device example; its recommendations do not apply automatically to every consumer or industrial product. The explanation and examples are original. Public catalogue access is not treated as permission to republish the standard. A correction request can identify the document, disputed statement and supporting official evidence for review.